Top member reports
No meetings
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
##shortfall offering
Added a month ago

TruScreen has a shortfall offering from their latest rights offering.

Price $0.0187 AUD per share

Current price is $0.026

TruScreen Group Limited (NZX/ASX: TRU) is a medical device company that has developed and manufactures an AI-enabled device for detecting abnormalities in the cervical tissue in real-time via measurements of the low level of optical and electrical stimuli.  

40% growth in sales of devices and a 22% growth in Single Disposable Sensors (SUS) for the nine months ending December 2023 compared to the same period the previous year. 

SUS unit sales exceeded total of last financial year, reaching 141,300 by 31 December 2023 (9 months)

• China continuing to be major contributor • Zimbabwe tender won and invoiced for 10,800 SUS 

Recent expansion into Mexico, Saudi Arabia - getting away from being dependent on Chinese market.


 

Read More